Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 57
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 38
Endocannabinoid System: Chemical Characteristics and Biological Activity
Bismarck Rezende, A Alencar, Graziele Freitas de, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 148-148
Open Access | Times Cited: 37
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity
Valentina Castelli, Gianluca Lavanco, Salvatore Feo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 692-692
Open Access | Times Cited: 13
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 4
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 4
Neuroprotection vs. Neurotoxicity: The Dual Impact of Brain Lipids in Depression
Yuting Yan, Yan Zhang, Mengting Liu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2722-2722
Open Access
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior
Emanuela Micioni Di Bonaventura, Luca Botticelli, Fabio Del Bello, et al.
Pharmacological Research (2021) Vol. 172, pp. 105847-105847
Open Access | Times Cited: 28
Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity
Marzie Khavandi, Praveen P. N. Rao, Michael A. Beazely
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 911-911
Open Access | Times Cited: 12
Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract
Jerome Lian, Ilaria Casari, Marco Falasca
Pharmacological Research (2021) Vol. 175, pp. 106025-106025
Closed Access | Times Cited: 24
The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
Hayatte-Dounia Mir, Giada Giorgini, Vincenzo Di Marzo
Psychoneuroendocrinology (2023) Vol. 154, pp. 106295-106295
Closed Access | Times Cited: 10
The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse
Rodrigo Zamith Cunha, Letícia Locatelli Felisardo, Giulia Salamanca, et al.
Veterinary and Animal Science (2023) Vol. 19, pp. 100289-100289
Open Access | Times Cited: 9
rTMS ameliorates depressive‐like behaviors and regulates the gut microbiome and medium‐ and long‐chain fatty acids in mice exposed to chronic unpredictable mild stress
Cuihong Zhou, Yihuan Chen, Shan‐Shan Xue, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 11, pp. 3549-3566
Open Access | Times Cited: 8
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 12
CB2 regulates oxidative stress and osteoclastogenesis through NOX1-dependent signaling pathway in titanium particle-induced osteolysis
Huaqiang Tao, Xueyan Li, Miao Chu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment
Gabriela Dumitrița Stanciu, Daniela Carmen Ababei, Carmen Solcan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 530-530
Open Access | Times Cited: 1
Neuroprotective Effects of Cannabispirenone A against NMDA-Induced Excitotoxicity in Differentiated N2a Cells
Sonia Thapa, Yedukondalu Nalli, Ajeet Singh, et al.
Oxidative Medicine and Cellular Longevity (2024) Vol. 2024, pp. 1-11
Open Access | Times Cited: 1
Maternal obesity induces sex-specific changes in the endocannabinoid system of the hypothalamus and dorsal hippocampus of offspring associated with anxiety-like behavior in adolescent female rats
Camila Calviño, Mariana Macedo de Almeida, Clara F. Reis-Gomes, et al.
Hormones and Behavior (2024) Vol. 166, pp. 105648-105648
Closed Access | Times Cited: 1
The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1
Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
Hiroki Ishiguro
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 4
Validation of a fast and sensitive UPLC-MS/MS quantitative method for N-acyl taurine analysis in biological samples
Gianna Falascina, Laure B. Bindels, Vincenzo Di Marzo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 226, pp. 115252-115252
Open Access | Times Cited: 3
Genetic variations in the retrograde endocannabinoid signaling pathway in Chinese patients with major depressive disorder
Huifang Xu, Tongtong Li, Qiyong Gong, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Sex-Related and Brain Regional Differences of URB597 Effects on Modulation of MAPK/PI3K Signaling in Chronically Stressed Rats
Milica Janković, Nataša Spasojević, Harisa Ferizović, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 3, pp. 1495-1506
Closed Access | Times Cited: 3
Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder?
Ruhan Deniz Topuz, Yasemin Görgülü, Milkibar Kyazim Uluturk
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 4, pp. 314-320
Closed Access | Times Cited: 5
Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
Gerwyn Morris, Ken Walder, Michael Berk, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 114, pp. 110481-110481
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top